methoxamine has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 6 (42.86) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, Q; Hauth, T; Hyman, A; Lippton, HL | 1 |
| Hodgson, WC; King, RG; Sikorski, BW | 1 |
| Humphrey, PP; Sumner, MJ | 1 |
| Armstead, WM; Hyman, AL; Kadowitz, PJ; Lippton, HL | 1 |
| Bellan, JA; Hyman, AL; Kadowitz, PJ; Lippton, HL | 1 |
| Rump, LC; Schollmeyer, P | 1 |
| Ohlstein, EH; Ruffolo, RR; Shebuski, RJ; Smith, JM | 1 |
| Sobey, CG; Sozzi, V; Woodman, OL | 1 |
| Ishine, T; Lee, TJ | 1 |
| Pfaffendorf, M; van Zwieten, PA; Winkler Prins, EA; Zwaveling, J | 1 |
| Bessard, G; Blin, D; Chavanon, O; Corompt, E; Cracowski, JL; Devillier, P; Stanke-Labesque, F; Veitl, S | 1 |
| Floten, SH; He, GW; Liu, MH; Yang, Q | 1 |
| Farmer, MR; Gardiner, SM; Ralevic, V; Roberts, RE | 1 |
| Bernhardt, F; Bertin, F; Félétou, M; Levy, BI; Michel, F; Paysant, J; Sansilvestri-Morel, P; Silvestre, JS; Simonet, S; Vayssettes-Courchay, C; Verbeuren, TJ | 1 |
14 other study(ies) available for methoxamine and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Mechanisms of signal transduction for adenosine and ATP in pulmonary vascular bed.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine; Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Cats; Dinoprost; GTP-Binding Proteins; Indomethacin; Methoxamine; Pertussis Toxin; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Quinoxalines; Signal Transduction; Thromboxane A2; Virulence Factors, Bordetella; Xanthines | 1992 |
Thromboxane A2 receptor stimulation similarly potentiates pressor responses to 5-hydroxytryptamine in perfused hindquarters of non-diabetic and alloxan diabetic rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Biphenyl Compounds; Diabetes Mellitus, Experimental; Drug Synergism; Hindlimb; Male; Methoxamine; Muscle, Smooth, Vascular; Perfusion; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Serotonin; Stimulation, Chemical; Thromboxanes; Vasoconstriction | 1991 |
Sumatriptan (GR43175) inhibits cyclic-AMP accumulation in dog isolated saphenous vein.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cyclic AMP; Dinoprostone; Dogs; Female; In Vitro Techniques; Indoles; Male; Methoxamine; Muscle, Smooth, Vascular; Prostaglandin Endoperoxides, Synthetic; Saphenous Vein; Sulfonamides; Sumatriptan | 1990 |
Influence of nisoldipine on vascular resistance and vasoconstrictor responses in cats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Azepines; Blood Pressure; Brimonidine Tartrate; Cardiac Output; Cats; Dinoprost; Dioxanes; Electric Stimulation; Female; Idazoxan; Male; Methoxamine; Nifedipine; Nisoldipine; Norepinephrine; Phenylephrine; Prostaglandin Endoperoxides, Synthetic; Prostaglandins F; Quinoxalines; Splanchnic Circulation; Sulfonamides; Sympathetic Nervous System; Tyramine; Vascular Resistance; Vasoconstriction | 1987 |
Nisoldipine inhibits vasoconstrictor responses in the cat pulmonary vascular bed.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Azepines; Calcium Channel Blockers; Cats; Female; Male; Methoxamine; Nifedipine; Nisoldipine; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Vasoconstriction; Vasodilator Agents | 1989 |
Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidney.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Dinoprost; Dinoprostone; Electric Stimulation; Epoprostenol; In Vitro Techniques; Kidney; Male; Methoxamine; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Prostaglandins, Synthetic; Rats; Rats, Inbred Strains; Renal Circulation; Sympathetic Nervous System | 1989 |
Enhanced pulmonary alpha-2 adrenoceptor responsiveness under conditions of elevated pulmonary vascular tone.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Azepines; Blood Pressure; Dinoprost; Dogs; Female; Lung; Male; Methoxamine; Prazosin; Prostaglandin Endoperoxides, Synthetic; Prostaglandins F; Receptors, Adrenergic, alpha; Serotonin; Vasoconstriction; Yohimbine | 1987 |
Ischaemia/reperfusion enhances phenylephrine-induced contraction of rabbit aorta due to impairment of neuronal uptake.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Aorta; Endothelium, Vascular; Female; In Vitro Techniques; Male; Methoxamine; Neurons; Phenylephrine; Prostaglandin Endoperoxides, Synthetic; Rabbits; Reperfusion Injury; Serotonin; Sympathetic Nervous System; Thromboxane A2; Vasoconstriction | 1994 |
Norepinephrine attenuates serotonin inhibition of pial venous tone.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenylate Cyclase Toxin; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Cerebral Veins; Clonidine; Cyclic AMP; Dose-Response Relationship, Drug; Female; Male; Methoxamine; Norepinephrine; Pertussis Toxin; Prostaglandin Endoperoxides, Synthetic; Serotonin Antagonists; Swine; Thromboxane A2; Vasoconstriction; Virulence Factors, Bordetella; Yohimbine | 1996 |
The influence of hyperthyroidism on beta-adrenoceptor-mediated relaxation of isolated small mesenteric arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Colforsin; Dose-Response Relationship, Drug; Hyperthyroidism; Imidazoles; Isoproterenol; Male; Mesenteric Arteries; Methoxamine; Muscle Contraction; Muscle Relaxation; Propanolamines; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Wistar; Thromboxane A2; Thyroxine; Vascular Resistance; Vasoconstrictor Agents | 1996 |
Thromboxane A(2) modulates cyclic AMP relaxation and production in human internal mammary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 8-Bromo Cyclic Adenosine Monophosphate; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Mammary Arteries; Methoxamine; Nitroprusside; Thromboxane A2; Vasoconstriction; Vasodilation | 2000 |
Inhibition of vasoconstriction by AJ-2615, a novel calcium antagonist with alpha(1)-adrenergic receptor blocking activity in human conduit arteries used as bypass grafts.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Calcium Channel Blockers; Coronary Artery Bypass; Dibenzothiepins; Dose-Response Relationship, Drug; Endothelin-1; Female; Humans; In Vitro Techniques; Male; Mammary Arteries; Methoxamine; Middle Aged; Norepinephrine; Piperazines; Potassium Chloride; Prazosin; Serotonin; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2001 |
Effects of in vivo lipopolysaccharide infusion on vasoconstrictor function of rat isolated mesentery, kidney, and aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta; Calcium; Dose-Response Relationship, Drug; Endotoxemia; In Vitro Techniques; Kidney; Lipopolysaccharides; Male; Mesenteric Arteries; Mesentery; Methoxamine; Potassium Chloride; Rats; Rats, Sprague-Dawley; Renal Artery; Vasoconstriction; Vasoconstrictor Agents | 2003 |
Altered TP receptor function in isolated, perfused kidneys of nondiabetic and diabetic ApoE-deficient mice.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Apolipoproteins E; Atherosclerosis; Diabetes Mellitus, Experimental; Dinoprost; Disease Models, Animal; Epoprostenol; Kidney; Male; Methoxamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Naphthalenes; Propionates; Receptors, Thromboxane A2, Prostaglandin H2; Streptozocin; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2008 |